Waid DM - Search Results

1

An analytical workflow for investigating cytokine profiles.

Siebert JC, Inokuma M, Waid DM, Pennock ND, Vaitaitis GM, Disis ML, Dunne JF, Wagner DH Jr, Maecker HT. Siebert JC, et al. Among authors: waid dm. Cytometry A. 2008 Apr;73(4):289-98. doi: 10.1002/cyto.a.20509. Cytometry A. 2008. PMID: 18163472 Free article.

2

Peripheral CD4loCD40+ auto-aggressive T cell expansion during insulin-dependent diabetes mellitus.

Waid DM, Vaitaitis GM, Wagner DH Jr. Waid DM, et al. Eur J Immunol. 2004 May;34(5):1488-97. doi: 10.1002/eji.200324703. Eur J Immunol. 2004. PMID: 15114683 Free article.

3

A unique T cell subset described as CD4loCD40+ T cells (TCD40) in human type 1 diabetes.

Waid DM, Wagner RJ, Putnam A, Vaitaitis GM, Pennock ND, Calverley DC, Gottlieb P, Wagner DH Jr. Waid DM, et al. Clin Immunol. 2007 Aug;124(2):138-48. doi: 10.1016/j.clim.2007.05.003. Epub 2007 Jun 8. Clin Immunol. 2007. PMID: 17560173

4

Disruption of the homeostatic balance between autoaggressive (CD4+CD40+) and regulatory (CD4+CD25+FoxP3+) T cells promotes diabetes.

Waid DM, Vaitaitis GM, Pennock ND, Wagner DH Jr. Waid DM, et al. J Leukoc Biol. 2008 Aug;84(2):431-9. doi: 10.1189/jlb.1207857. Epub 2008 May 9. J Leukoc Biol. 2008. PMID: 18469093 Free PMC article.

5

CD40 engagement of CD4+ CD40+ T cells in a neo-self antigen disease model ablates CTLA-4 expression and indirectly impacts tolerance.

Carter J, Vaitaitis GM, Waid DM, Wagner DH Jr. Carter J, et al. Among authors: waid dm. Eur J Immunol. 2012 Feb;42(2):424-35. doi: 10.1002/eji.201141880. Eur J Immunol. 2012. PMID: 22105491 Free article.

6

An alternative role for Foxp3 as an effector T cell regulator controlled through CD40.

Vaitaitis GM, Carter JR, Waid DM, Olmstead MH, Wagner DH Jr. Vaitaitis GM, et al. Among authors: waid dm. J Immunol. 2013 Jul 15;191(2):717-25. doi: 10.4049/jimmunol.1300625. Epub 2013 Jun 17. J Immunol. 2013. PMID: 23776180 Free PMC article.

7

Defining a new biomarker for the autoimmune component of Multiple Sclerosis: Th40 cells.

Waid DM, Schreiner T, Vaitaitis G, Carter JR, Corboy JR, Wagner DH Jr. Waid DM, et al. J Neuroimmunol. 2014 May 15;270(1-2):75-85. doi: 10.1016/j.jneuroim.2014.03.009. Epub 2014 Mar 15. J Neuroimmunol. 2014. PMID: 24690203 Free PMC article.

8

A CD40-targeted peptide controls and reverses type 1 diabetes in NOD mice.

Vaitaitis GM, Olmstead MH, Waid DM, Carter JR, Wagner DH Jr. Vaitaitis GM, et al. Among authors: waid dm. Diabetologia. 2014 Nov;57(11):2366-73. doi: 10.1007/s00125-014-3342-5. Epub 2014 Aug 8. Diabetologia. 2014. PMID: 25104468 Free PMC article.

9

Th40 cells (CD4+CD40+ Tcells) drive a more severe form of Experimental Autoimmune Encephalomyelitis than conventional CD4 T cells.

Vaitaitis GM, Yussman MG, Waid DM, Wagner DH Jr. Vaitaitis GM, et al. Among authors: waid dm. PLoS One. 2017 Feb 13;12(2):e0172037. doi: 10.1371/journal.pone.0172037. eCollection 2017. PLoS One. 2017. PMID: 28192476 Free PMC article.

10

CD40-mediated signalling influences trafficking, T-cell receptor expression, and T-cell pathogenesis, in the NOD model of type 1 diabetes.

Vaitaitis GM, Waid DM, Yussman MG, Wagner DH Jr. Vaitaitis GM, et al. Among authors: waid dm. Immunology. 2017 Oct;152(2):243-254. doi: 10.1111/imm.12761. Epub 2017 Jun 19. Immunology. 2017. PMID: 28542921 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters